Showing results (501-510 of 582) with videos related to
Sort By:
Pageof 59
Toxins|September 26, 2025
Development of a Patient-Centered Outcome Tool for Blepharospasm: A Stepwise Modified Delphi StudyBrian D Berman, Fares Qeadan, Amanda D Henderson, et al.Journal of Neurology|October 15, 2023
Longitudinal predictors of health-related quality of life in isolated dystoniaJohanna Junker, James Hall, Brian D Berman, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 10, 2021
Quality of life in isolated dystonia: non-motor manifestations matterJohanna Junker, Brian D Berman, James Hall, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 26, 2017
Psychiatric associations of adult-onset focal dystonia phenotypesBrian D Berman, Johanna Junker, Erika Shelton, et al.Mass Spectrometry Reviews|April 10, 2009
Glycoproteomics in neurodegenerative diseasesHyejin Hwang, Jianpeng Zhang, Kathryn A Chung, et al.Dystonia (Lausanne, Switzerland)|April 27, 2023
From null to midline: changes in head posture do not predictably change head tremor in cervical dystoniaJeanne P Vu, Elizabeth Cisneros, Jerry Zhao, et al.Brain : a Journal of Neurology|February 17, 2010
DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's diseaseZhen Hong, Min Shi, Kathryn A Chung, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 5, 2007
Potential outcome measures and trial design issues for multiple system atrophySusanne May, Sid Gilman, B Brooke Sowell, et al.Parkinsonism & Related Disorders|December 28, 2024
Factor analysis and clustering of motor and psychiatric dimensions in idiopathic blepharospasmAngelo F Gigante, Mark Hallett, Hyder A Jinnah, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 28, 2013
Designing clinical trials for dystoniaWendy R Galpern, Christopher S Coffey, Alberto Albanese, et al.Pageof 59